newsfilter
← Latest News
GlobeNewswire·

PolyPid Announces Participation in Upcoming Fall Investor Conferences

  • PolyPid Ltd. (NASDAQ: PYPD) senior management will attend the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, in New York, featuring a panel on regulatory uncertainty & capital constraints.
  • PolyPid will present at the Lytham Partners Fall 2026 Investor Conference on September 29, 2026, with virtual one-on-one investor meetings scheduled for September 30, 2026.
  • PolyPid will participate in the Craig-Hallum 17th Annual Alpha Select Conference on November 17, 2026, in New York, offering one-on-one investor meetings.
  • PolyPid's lead product, D-PLEX 100, successfully met primary & key secondary endpoints in the Phase 3 SHIELD II trial for preventing surgical site infections.
  • PolyPid develops long-acting, controlled-release drugs targeting surgical care, metabolic diseases, & other unmet medical needs.